On the other hand, abnormal epigenetic regulation of Foxp3 in Treg cells has been documented in SLE patients, which suggests that hypermethylation of the Foxp3+ promoter region is associated with a decreased proportion of Treg cells and increased disease activity (Zhao et al., 2012). The gene discussed is FOXP3; the disease is systemic lupus erythematosus.